Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (520880) has decreased by 1.09%, with the latest price at 0.546 yuan and a turnover rate of 8.58% [1] - The ETF closely tracks the Hang Seng Hong Kong Stock Connect Innovative Drug Selected Index, which includes companies involved in the research, development, and production of innovative drugs [1] - The latest scale of the ETF reached 2.124 billion yuan, with a total of 3.860 billion shares, reflecting an increase of 0.088 billion yuan over the past month [1] Group 2 - Notable stock performances within the index include Kangzheng Pharmaceutical up by 1.17%, China Biopharmaceutical up by 1.03%, and CSPC Pharmaceutical up by 0.27%, while Kangfang Biotech down by 3.38%, 3SBio down by 3.36%, and Innovent Biologics down by 2.63% [1] - The ETF has seen a net inflow of 56.4796 million yuan as of the previous trading day, with a total of 60.919 million yuan raised over the past week [1]
港股通创新药高开低走，520880跌逾1％，场内溢价快速拉高，低吸资金涌动
Xin Lang Cai Jing·2025-12-09 06:20